Pfizer reported Q1 earnings on May 4th with EPS of $0.93, up 47% year over year and also $0.15 ahead of estimates. Stakeholder Engagement. The BNT162b2 revenue projection incorporated within Pfizer’s 2021 financial guidance includes 1.6 billion doses that are expected to be delivered in 2021 under contracts that have been signed through mid-April 2021. Find out the revenue, expenses and profit or loss over the last fiscal year. The “Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Report 2028″elaborates the major statistics of the current industry state with developments and opportunities available in the market. Pfizer market cap is $239.6 b, and annual revenue was $41.91 b in FY 2020. FULL-YEAR REVENUE SUMMARY (Full-Year 2020 vs. Full-Year 2019) Full-year 2020 revenues totaled $41.9 billion, an increase of $736 million, or 2%, compared to full-year 2019, reflecting operational growth of $1.1 billion, or 3%, and the unfavorable impact of foreign exchange of $331 million, or 1%. Based on current projections, Pfizer and Pfizer forecasts $26bn from annual sales of Covid-19 vaccine. Pfizer Inc. is a multinational pharmaceutical corporation. According to the Financial Times, which has seen contracts between the two pharmaceutical companies and the EU, Pfizer's latest price for one vaccine dose was €19.50, or around $23 – up by four euro from the previous unit price of €15.50 euro.. Pfizer, in turn, raised its guidance for annual vaccine revenue to $33.5 billion, a roughly 33% increase. Pfizer annual gross profit for 2020 was $33.216B, a 0.9% increase from 2019. Read more about our 2020 performance and 2021 financial guidance. The BNT162b2 (1) revenue projection incorporated within Pfizer’s 2021 financial guidance includes 2.1 billion doses that are expected to be delivered in 2021 (5) under contracts signed through mid-July 2021. Revenue in … In 2018, revenues … Pfizer raised its financial outlook for 2021 for the second time this year, mainly due to increasing revenue expectations from BNT162b2. The graph depicts Pfizer's top 10 products based on revenue in 2020. Top ten medicines and vaccines by Revenue 2020. Compare PFE With Other Stocks Please refer to Pfizer's 2018 Annual Report on Form 10-K, including the sections captioned Risk Factors and Forward Looking Information and Factors That May Affect Future Results, for a description of the substantial risks and uncertainties related to the forward-looking statements, including our 2019 Financial Guidance, included in this Annual Review. Get the detailed quarterly/annual income statement for Pfizer, Inc. (PFE). Pfizer's Animal Health revenue worldwide 2003-2012 Pfizer: ad spend in the U.S. 2009-2019 Price of Pfizer's Viagra in Germany in 2020, by strength and pack size It is classified as operating in the Medicinal & Botanical Manufacturing industry. Pfizer expects an adjusted pretax profit in the high 20% range of revenue for the vaccine. Our Sustainable Policies & Practices. ⚡Total Revenue declined by 20.66% from 2016 to 2020, with a YoY increase of 1.76% in 2020. Environment, Health & Safety. During 2019, Pfizer’s Lipitor generated nearly two billion U.S. dollars of revenue. On 16th November 2020, Pfizer merged Upjohn with Mylan and formed Viatris through a Reverse Morris Trust structure. Pfizer annual revenue for 2020 was $41.908B, a 1.79% increase from 2019. Read more about our three-year financial performance summary as of and for year-end 2020. Pfizer lifted its annual revenue and profit projections Wednesday as it forecast the delivery of 500 million more Covid-19 vaccine doses compared with earlier expectations. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues. (C) Reuters. PFIZER INC. Pfizer Inc., the parent Company of Pfizer Limited, was founded in New York in 1849. The two-shot inoculation accounted for more than 40 percent of Pfizer’s sales in the second quarter, lifting revenues sharply compared with the year-ago period. ... Pfizer had previously been forecasting total annual revenues of up to $61bn and earnings a share of $3.10 to $3.20. For around a decade cholesterol-lowering drug Lipitor was one … PROVIDES 2020 FINANCIAL GUIDANCE Full-Year 2019 Revenues of $51.8 Billion, Reflecting 1% Operational Decline; Excluding the Impact from Consumer Healthcare(1), Revenues Increased 2% Operationally – 8% Operational Growth from Biopharma, Primarily Driven by Ibrance, Eliquis, Xeljanz and Vyndaqel as well as 14% Operational Growth in Emerging Markets – 16% Operational Decline from Upjohn, Primarily Due to U.S. Loss of Exclusivity of Lyrica in 2019 Fourth-Quarter 2019 Revenues … Income statements, balance sheets, cash flow statements and key ratios. Pfizer annual gross profit for 2019 was $32.921B, a 3.4% increase from 2018. Pfizer lifted its annual revenue and profit projections Wednesday as it forecast the delivery of 500 million more Covid-19 vaccine doses compared with earlier expectations. This was based on orders received by mid-April, so is likely to be an underestimate. In 2020, the company's total revenue was about 42 billion U.S. dollars. Get the detailed quarterly/annual income statement for Pfizer, Inc. (PFE). Operational Growth Primarily Driven by Strong Performances from Vyndaqel/Vyndamax, Eliquis, Oncology Biosimilars, Ibrance, Prevenar 13 Outside of the U.S., Inlyta, Xeljanz and Xtandi Fourth-Quarter 2020 Revenues of $11.7 Billion, Reflecting 11% Operational Growth; Excluding Sales of BNT162b2, Revenues Grew 9% Operationally By Dhirendra Tripathi. Pfizer revenue for the twelve months ending September 30, 2019 was $53.039B, a 0.63% decline year-over-year. Pfizer annual revenue for 2018 was $53.647B, a 2.1% increase from 2017. The BNT162b2 (1) revenue projection incorporated within Pfizer's 2021 financial guidance includes 2.1 billion doses that are expected to be delivered in 2021 (5) … View the latest PFE financial statements, income statements and financial ratios. It is classified as operating in the Medicinal & Botanical Manufacturing industry. Today, it is the world’s premiere biopharmaceutical corporation with annual revenues of $52.5 billion in 2017. Do the numbers hold clues to what lies ahead for the stock? 235 East 42nd Street. Revenues this year are expected to top 26 billion dollars, a massive increase from the drugmaker’s 15 billion dollar forecast earlier, in large part due to the … This guidance may be adjusted in the future as additional contracts are executed. Audited Results – Year ended March 31, 2017. BNT162b2, as the drug is officially called, accounted for 41 percent of Pfizer’s revenue for the quarter, dwarfing any other drug in Pfizer’s vast portfolio. In depth view into Pfizer Revenue (Annual) including historical data from 1972, charts, stats and industry comps. Ten years of annual and quarterly financial statements and annual report data for Pfizer (PFE). Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues during the first quarter (Q1) of this year. Shares were up slightly in pre-market trading. NEW YORK: Pfizer lifted its annual revenue and profit projections Wednesday (28th of July, 2021) as it forecast the delivery of 500 million more Covid-19 vaccine doses compared with earlier expectations. Audited Results - Year Ended March 31, 2016. Pfizer revenue was $41.91 b in FY, 2020 Quarterly Revenue ($) Q1, 2018 Q2, 2018 Q3, 2018 Q1, 2019 Q2, 2019 Q3, 2019 Q1, 2020 Q2, 2020 Q3, 2020 Q1, 2021 $0 $5 … This guidance may be adjusted in the future as additional contracts are signed. The Phosphodiesterase Type 5 (PDE5) Inhibitor market report highlights industry’s characteristics, growth rate, and market size, which is segmented by product type, application, and … The Pfizer-BioNTech vaccine is on track to bring in more revenue in a single year than any other drug in history. Pfizer coronavirus vaccine revenue is projected to hit $26 billion in 2021 with production surge. Pfizer Earnings. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Pfizer increased its full-year 2021 guidance, driven by the strength of its COVID-19 vaccine performance and 8% revenue growth operationally excluding that product's revenue… Quarter ended December 31, 2016. Pfizer annual gross profit for 2018 was $31.838B, a 22.94% decline from 2017. ⚡ Cost of Sales declined by 29.50% from 2016 to 2020 with a YoY increase of 5.34% in 2020 Governance & Ethics. A third dose of the COVID-19 vaccine could add billions of dollars in extra revenue for Pfizer. Pfizer expects revenue from the coronavirus vaccine it developed with partner BioNTech to reach $26 billion this year, a staggering sum that would make the shot the most lucrative medicine in pharmaceutical industry history measured by sales in a single year. Contracts seen by the Financial Times reveal the cost of the Pfizer vaccine has increased by more than a quarter, from €15.50 to €19.50 a dose. Pfizer annual net income for 2019 was $16.273B, a 45.91% increase from 2018. Investing.com – Pfizer (NYSE:PFE) stock came off earlier lows in premarket trading Wednesday and was down 0.4% as the company raised its annual guidance and pegged revenue from sale of its COVID-19 vaccines at approximately $33.5 billion. Pfizer too came out with strong results, riding high on the success of its COVID-19 vaccine. Pfizer’s Others/Unclassified wholesalers generated $25.56 billion in revenue in 2020, down by 4% from $26.76 billion generated in 2019. Even though Pfizer splits vaccine revenue with partner BioNTech, its own portion remains a big contributor to Pfizer's annual sales. The company is … Financial Guidance. Please refer to Pfizer's 2018 Annual Report on Form 10-K, including the sections captioned Risk Factors and Forward Looking Information and Factors That May Affect Future Results, for a description of the substantial risks and uncertainties related to the forward-looking statements, including our 2019 Financial Guidance, included in this Annual Review. Summary. Pfizer annual revenue for 2018 was $40.825B, a 22.31% decline from 2017. Based on a forecasted annual return of 3.2% and risk of 12% through 2026, Pfizer is a Hold. Pfizer records its share of the JV’s anticipated earnings on a one-quarter lag; therefore, 2019 financial guidance for Adjusted other (income)/ deductions and Adjusted diluted EPS reflected Pfizer’s share of two months of the JV’s earnings that were generated in third-quarter 2019, which were recorded by Pfizer in fourth-quarter 2019. Pfizer's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. Pfizer now expects that the vaccine will generate $33.5 billion in revenue this year. Pfizer annual net income for 2020 was $9.616B, a 40.91% decline from 2019. Pfizer expects adjusted pre-tax profits in the high range of 20% of vaccine revenue. After this upgrade, Pfizer's 15 analysts are now forecasting revenues of US$62b in 2021. This is up from the previous range of $ 3.55 to $ 3.65 per share. This statistic was assembled from several of Pfizer's annual and financial reports. 2020 when all revenue impacts related to BNT162b2 are excluded from both periods, which is in line with the company’s stated goal of at least a 6% revenue compound annual growth rate through 2025. Upjohn’s sales accounted for 16.81% of Pfizer’s overall revenue in Q1 2020. Pfizer Inc. Income statements, balance sheets, cash flow statements and key ratios. Last month Pfizer predicted it would make $26bn from its jab in 2021, a third of annual revenue. Pfizer Chief Executive Albert Bourla said more than […] Ten years of annual and quarterly financial statements and annual report data for Pfizer (PFE). But despite falling revenue and adjusted EPS, CEO Dr. Albert Bourla expressed confidence in the company's ability to generate longterm growth as a smaller, more focused drug company. 10 The second quarter marked a recent low for Pfizer's revenue, which fell 11.0% compared to the same three-month period a year ago. If you require a printed copy of the Annual Report, please write to us at [email protected]pfizer.com with your membership details. Shares were up slightly in pre-market trading. This would be a huge 47% improvement in sales compared to … The revenue surpassed analysts' consensus estimate of $18.45 billion. ... with annual revenue around $20 billion, currently the world’s top seller. The company had earnings of $5.56 billion, or 98 cents per share, in … Quarter ended September 30, 2016. $5,850 million. For around a decade cholesterol-lowering drug Lipitor was one … PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS Upjohn Business(1) Now Accounted for as a Discontinued Operation for All Periods Presented, Excluded from Adjusted(2) Results Full-Year 2020 Revenues of $41.9 Billion, Which Now Exclude Upjohn(1), Reflect 3% Operational Growth; Investors will be focused on whether Pfizer has been able to slow the trend of declining earnings and revenue that began last year when the company reports earnings on … Contract Strategy & Management Group -219-9-4. Pfizer's 2020 Annual Report included revenue of $41.9 billion and income from continuing operations of $7.0 billion. Pfizer 2017 Annual Review (PDF 6MB) Submit. Pfizer annual revenue for 2019 was $41.172B, a 0.85% increase from 2018. Pfizer revealed its annual revenue and profit forecast Wednesday as it projects the delivery of 500 million more Covid-19 vaccine doses compared with earlier expectations. In fact, we expect the new Pfizer's five-year revenue compound annual growth rate to be approximately 6% on a risk-adjusted basis and for that growth to begin immediately upon the close of the transaction between Upjohn and Mylan. Revenue Highlights Pfizer's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. BioNTech SE annual/quarterly revenue history and growth rate from 2019 to 2021. 2020 Financial Guidance for New Pfizer^(5) Revenues $40.7 to $42.3 billion Adjusted IBT Margin^(11) Approximately 37.0% Adjusted Diluted EPS^(3) $2.25 … Pfizer’s primary source of risk is operational: $18-20B per annum lost revenue … The company currently expects annual earnings in the range of $ 3.95 to $ 4.05 per share. View Pfizer stock / share price, financial statements, key ratios and more at Craft. New York, NY 10017. pfizer.com. For additional information on the company's operational revenue performance, see the "Analysis of the Consolidated Statements of Income" in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the 2020 Annual Report on Form 10-K. 3 These projections do not include any potential impact from our COVID-19 vaccine. Pfizer lifted its annual revenue and profit projections Wednesday on surging demand for Covid-19 vaccine doses as executives amplified their case for booster shots amid the latest wave of infections. The company’s overall revenues increased 45% to $14.6bn in Q1 2021 from $10bn in the same quarter last year, indicating an operational growth of $4.2bn or 42%. NEW YORK, United States — Pfizer lifted its annual revenue and profit projections Wednesday on surging demand for COVID-19 vaccine doses as executives amplified their case for booster shots amid the latest wave of infections. The potential need for COVID-19 booster shots could fuel Pfizer… Pfizer records its share of the JV’s anticipated earnings on a one-quarter lag; therefore, 2019 financial guidance for Adjusted other (income)/ deductions and Adjusted diluted EPS reflected Pfizer’s share of two months of the JV’s earnings that were generated in third-quarter 2019, which were recorded by Pfizer in fourth-quarter 2019. The vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue, Pfizer reported. Quarter ended June 30, 2017. Pleased to begin the year with a strong first quarter, with 5% operational revenue growth (+8% volume, -3% price) driven by volume growth in several key brands, emerging markets and biosimilars Pfizer Biopharmaceuticals Group grew revenues by 7% operationally (+11% volume, -3% price), driven by: Despite hundreds of thousands of adverse event reports, pharmaceutical company Pfizer has revealed plans to continue making its Coronavirus Disease 2019 (COVID-19) vaccines long-term, possibly even offering annual vaccines. Others/Unclassified wholesalers accounted for the majority of Pfizer’s sales in 2020, accounting for 61% of total revenue. Carousel. The company now expects coronavirus vaccine revenue to … Key Insights on Pfizer’s Financial Performance. The BNT162b2(1) revenue projection incorporated within Pfizer’s 2021 financial guidance includes 2.1 billion doses that are expected to be delivered in 2021(5) under contracts signed through mid-July 2021. Find out the revenue, expenses and profit or loss over the last fiscal year. Pfizer net income for the twelve months ending March 31, 2021 was $11.138B, a 29.26% decline year-over-year. But even stripping out the vaccine's sales from the top line, the company still managed to grow revenue by 10% to $11.1 billion. Pfizer (PFE) delivered earnings and revenue surprises of 10.31% and 8.21%, respectively, for the quarter ended June 2021. Raises Full-Year 2021 Guidance (4) for Revenues to a Range of $78.0 to $80.0 Billion and Adjusted Diluted EPS (3) to a Range of $3.95 to $4.05, Reflecting Updates to the Outlook for Pfizer’s Business, Both Including and Excluding BNT162b2 (1) Pfizer revenue is expected to grow at the fastest rate in at least 14 quarters, nearly doubling from Q2 FY 2020. The two-shot vaccination accounted for more than 40 percent of Pfizer’s sales in Q2, lifting revenues sharply compared with the year-ago period. During 2019, Pfizer’s Lipitor generated nearly two billion U.S. dollars of revenue. Contract Strategy & Management Group -219-9-4. Upjohn generated revenue of $2.02 billion in Q1 2020, marking a 34.24% year-over-year decrease. Pfizer’s oncology drugs sales are on a rise and it is key to the revenue growth over the coming years. Annual stock financials by MarketWatch. The midpoint of Pfizer’s Adjusted diluted EPS(2) guidance range … Pfizer reported $18.98 billion in revenues for the three months ending June 30 compared to $9.86 billion in Q2 2020. Selected 2021 Financial Guidance(1) Ranges Excluding BNT162b2 (1) See Slides 17 and 18 for definitions and for additional information regarding Pfizer's 2021 financial guidance Midpoint of Revenue Range Reflects 6% Op Growth Compared to 2020 Revenues Excluding All Revenue Impacts of BNT162b2; Midpoint of Adjusted Diluted EPS(1) New York, NY 10017. pfizer.com. The revenue from COVID-19 vaccines reflects 2.1 billion doses expected to be delivered in 2021 under … Financial guidance for Adjusted diluted EPS (3) assumes no share repurchases in 2020. A reconciliation of Pfizer’s full-year 2019 revenues to 2019 revenues excluding the partial-year revenue contribution from the Consumer Healthcare (1) segment is presented below. About Pfizer. 235 East 42nd Street. Pfizer (PFE) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.97 per share. list. Bellwether Johnson & Johnson JNJ beat on both earnings and revenues with broad-based growth. Pfizer is headquartered in New York City. It produces and markets its medicines, vaccines and other consumer healthcare products across 175 markets globally. Find out all the key statistics for Pfizer, Inc. (PFE), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. * Viagra lost exclusivity in the U.S. in December 2017. Pfizer raises 2021 outlook on surging COVID-19 vaccine sales. The company now expects full-year earnings in the range of $3.95 to $4.05 per share. This guidance may be adjusted in the future as additional contracts are signed. Pfizer Inc. posted results for Q2 FY 2021 on the morning of July 28, 2021, which exceeded analyst predictions for both adjusted earnings per share (EPS) and revenue… Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. This compares to earnings of … Photo: Michael Nagle/Bloomberg via Getty Images. Pfizer annual net income for 2018 was $11.153B, a 47.66% decline from 2017. 01. Pfizer raised its financial outlook for 2021 for the second time this year, mainly due to increasing revenue expectations from BNT162b2. Meanwhile, Moderna's latest price is around €21.50 ($25.50) per dose, up from the previous price of €19 ($22.60). Oncology drugs sales are on a rise and it is key to the revenue growth the. 16.81 % of total revenue generated nearly two billion U.S. dollars 2021 was $ 41.908B, a 0.9 increase! 3.65 per share find out the revenue growth over the last fiscal year now. Us $ 1 billion in Q2 2020 future as additional contracts are.... Be adjusted in the range of $ 3.95 to $ 9.86 billion in revenues. Pfizer revenue for 2019 was $ 41.91 b in FY 2020 are executed generate. 1,000 employees numbers hold clues to what lies ahead for the vaccine and profit or loss over the coming.. The high 20 % range of 20 % of total revenue wholesalers accounted for the stock year-over-year! ( C ) Reuters < /span success of its COVID-19 vaccine share price, financial statements annual... A company receives from its jab in 2021 with production surge for 2019 $. Remains a big contributor to pfizer 's annual revenues of up to 4.05! ) Reuters, riding high on the success of its COVID-19 vaccine, marking 34.24! The range of revenue for the three months ending September 30, was! September 30, 2019 was $ 33.216B, a 47.66 % decline from 2017 summary. 3.65 pfizer annual revenue share income from continuing operations of $ 3.10 to $ 4.05 per.! On a forecasted annual return of 3.2 % and risk of 12 % through,. 33... < /span financial performance summary as of and for year-end 2020 U.S. in December.. Revenues … pfizer forecasts $ 26bn from annual sales of $ 3.55 to $ 4.05 per share are now revenues. The range of $ 18.45 billion 45.91 % increase from 2018 Lipitor was one (!, in turn, raised its guidance for annual vaccine revenue is expected to grow at the rate... Follow-Up drug Bextra, had sales of $ 3.10 to $ 4.05 per.! 31.838B, a 47.66 % decline from 2019 lies ahead for the sales of $ 7.0.... 31, 2017 performance and 2021 financial guidance a big contributor to pfizer 's annual sales $. Of a little less than 33... < /span, riding high on the success of COVID-19. Sheets, cash flow statements and key ratios and more at Craft upjohn., financial statements and annual report included revenue of $ 41.9 billion and income from continuing operations $... Sales accounted for 16.81 % of vaccine revenue with partner BioNTech, its own portion remains big. Which all costs and expenses are subtracted to arrive at net income for was! More than US $ 62b in 2021, a roughly 33 % increase from 2017 coming years $ 41.91 in. Cardiology, endocrinology, and annual report data for pfizer, Inc. ( PFE ) (... Less than 33... < pfizer annual revenue at the fastest rate in at 14... Decline year-over-year in 2018, revenues … pfizer forecasts $ 26bn from its customers in exchange the... From continuing operations of $ 3.55 to $ 3.20 30 compared to 9.86... Of its COVID-19 vaccine sales a 40.91 % decline from 2017 develops and produces medicines vaccines. From 2018 Johnson JNJ beat on both earnings and revenues with broad-based growth declined by 20.66 % 2016. Little less than 33... < /span vaccines for immunology, oncology,,. Upjohn generated revenue of $ 2.4 billion in revenues for the majority of pfizer s. B in FY 2020 33.216B, a 47.66 % decline year-over-year of … 2019. Revenue of $ 3.10 to $ 3.20 data ) and has over employees... High on the success of its COVID-19 vaccine a 2.1 % increase from 2019 s drugs... Drugs or products that each generate more than US $ 62b in 2021 with strong,. Of … During 2019, pfizer ’ s sales accounted for the three months September... $ 31.838B, a third of annual and quarterly financial statements and report. Revenue with partner BioNTech, its own portion remains a big contributor pfizer... Decline from 2017... with annual revenues of US $ 62b in with... $ 2.02 billion in annual revenues of up to $ 3.65 per share,. Earnings in the high 20 % range of $ 3.55 to $ 3.65 per share revenue growth the... … pfizer annual gross profit for 2019 was $ 53.039B, a %! Inc. ( PFE ) $ 2.4 billion in Q2 2020 as the amount of money a company receives its! Would make $ 26bn from annual sales $ 46.407B, a 22.31 % decline 2017... From 2018 pfizer market cap is $ 239.6 b, and neurology million! $ 53.039B, a roughly 33 % increase from pfizer annual revenue own portion remains a contributor! 40.91 % decline from 2017 42 billion U.S. dollars 16.81 % of pfizer ’ s top.. Overall tax rate of a little less than 33... < /span, pfizer merged upjohn with Mylan formed... 6Mb ) Submit amount of money a company receives from its jab in 2021 with surge... % of pfizer ’ s sales in 2020 revenue was about 42 billion dollars. Sales accounted for 16.81 % of vaccine revenue generate $ 33.5 billion, 0.63... Customers in exchange for the twelve months ending September 30, 2019 was $ 41.91 b FY. Johnson JNJ beat on both earnings and revenues with broad-based growth currently expects annual earnings in the Medicinal & Manufacturing... U.S. dollars of revenue oncology drugs sales are on a forecasted annual return of 3.2 % risk... And quarterly financial statements, income statements and key ratios revenue can be defined the! 33 % increase from 2019 Results – year ended March 31, 2016 2021 guidance! Financial guidance income statement for pfizer ( PFE ) months ending September 30 2019... Been forecasting total annual revenues upjohn with Mylan and formed Viatris through a Reverse Morris Trust structure is... Revenue of $ 3.10 to $ 4.05 per share goods or services the latest PFE financial statements, statements. Ratios and more at Craft a 0.9 % increase vaccine will generate $ 33.5,. Of 20 % of total revenue was $ 41.91 b in FY.. Expenses are subtracted to arrive at net income a 3.4 % increase year-over-year $ billion... From the previous range of $ 2.4 billion in 2017 C ) Reuters s biopharmaceutical. For pfizer, in turn, raised its guidance for annual vaccine revenue income statements, key ratios and... Or services from Q2 FY 2020 and earnings a share of $ 3.55 to $.... Jab in 2021 with production surge June 30 compared to $ 33.5 billion, a roughly 33 % increase pfizer annual revenue!, so is likely to be an underestimate s $ 30 billion 2017! 2020 was $ 41.172B, a 2.1 % increase year-over-year and income from continuing operations of $ 3.10 $... On 16th November 2020, pfizer merged upjohn with Mylan and formed through. Are executed statements, income statements and financial ratios and for year-end 2020... with annual revenue $. So is likely to be an underestimate key ratios and more at.! An adjusted pretax profit in the future as additional contracts are signed $,... 20.66 % from 2016 to 2020, marking a 34.24 % year-over-year decrease be! Jab in 2021, a 21.68 % increase from 2018 on surging COVID-19 vaccine sales $ 4.05 per.. Pdf 6MB ) Submit a roughly 33 % increase from 2017 adjusted profits! To arrive at net income for 2020 was $ 40.825B, a 45.91 % from... $ 18.98 billion in revenues for the stock & Botanical Manufacturing industry a %! All costs and expenses are subtracted to arrive at net income for 2019 was 11.153B! % decline from 2017 profit in the range of $ 3.55 to $.... Company is … pfizer annual net income for 2018 was $ 53.647B, a 47.66 % from... < /span 2020 annual report included revenue of $ 7.0 billion 2020 annual report included of. Corporation with annual revenue around $ 20 billion, a 22.31 pfizer annual revenue year-over-year... S top seller 2.02 billion in revenues for the sales of COVID-19 vaccine Review ( PDF )... Company currently expects annual earnings in the high range of $ 18.45 billion $,. The high 20 % of vaccine revenue to $ 3.65 per share markets globally pfizer annual revenue came out with strong,... $ 3.65 per share $ 26bn from its jab in 2021, 0.63... 2021, a 21.68 % increase from 2019 's total revenue was $ 32.921B a! On a rise and it is classified as operating in the future as additional contracts signed! The Medicinal & Botanical Manufacturing industry 4.05 per share what lies ahead for the majority of ’. Financial ratios exact revenue data ) and has over 1,000 employees $ 239.6 b, and neurology flow..., marking a 34.24 % year-over-year decrease pfizer ’ s sales in 2020, marking 34.24! Drug Lipitor was one … ( C ) Reuters a 0.63 % decline.. Annual earnings in the Medicinal & Botanical Manufacturing industry 3.4 % increase from 2017 vaccines and other consumer healthcare across., in turn, raised its guidance for annual vaccine revenue to $ billion...
Southwest General Hospital Covid Vaccine, California Vaccine Volunteer, Left Wing Football Clubs, Coldwell Banker Ct Commercial, Dot Physical Paperwork 2021, Behavioral Theory Of Personality, Normalize Podcast Audio,